ClinConnect ClinConnect Logo
Search / Trial NCT06943599

Strategies for Improving Linkage-to-Care After Eye Disease Screening

Launched by UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · Apr 17, 2025

Trial Information

Current as of June 26, 2025

Not yet recruiting

Keywords

Eye Diseases Mass Screening Patient Compliance Retention In Care

ClinConnect Summary

This clinical trial is looking to find better ways to help people get the eye care they need after being screened for eye diseases like Age-Related Macular Degeneration, Diabetic Retinopathy, and Glaucoma. If you've participated in the Village Integrated Eye Worker II (VIEW II) study and were referred to an eye hospital after your screening, you might be eligible for this trial. Participants will be randomly assigned to one of three groups: one will receive text message reminders, another will have reminders from community health workers, and the last group will not receive any reminders. The main goal is to see if these different methods help encourage people to visit the eye hospital within 21 days of their screening.

The trial is not yet recruiting participants, and it is open to everyone aged 18 and older, as long as they live in an area with reliable mobile connectivity. If you join the trial, you can expect to either receive reminders to help you remember your appointment or not have any reminders at all, which will help the researchers understand the best ways to support people in getting the eye care they need. This trial is important because it aims to improve follow-up care for people with serious eye conditions, ultimately helping to protect their vision.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • - Participant of the VIEW II study referred to the eye hospital at their eye screening visit.
  • Exclusion Criteria:
  • Residence in a community without reliable mobile connectivity

About University Of California, San Francisco

The University of California, San Francisco (UCSF) is a leading academic institution renowned for its commitment to advancing healthcare through innovative research and clinical trials. With a focus on translating scientific discoveries into effective therapies, UCSF collaborates with a diverse array of stakeholders, including healthcare professionals, industry partners, and patient communities. The university's research programs emphasize interdisciplinary approaches and leverage cutting-edge technology to address complex medical challenges. As a sponsor of clinical trials, UCSF is dedicated to maintaining the highest standards of ethical conduct and scientific rigor, ensuring the safety and well-being of participants while contributing to the broader medical knowledge base.

Locations

San Francisco, California, United States

San Francisco, California, United States

Patients applied

0 patients applied

Trial Officials

Jeremy Keenan, MD, MPH

Principal Investigator

University of California, San Francisco

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported